 result multicent trial imipenem/cilastatin intra-abdomin infect multicent studi tobramycin/clindamycin intra-abdomin infect acut physiolog chronic health evalu apach II index sever patient infect nineti patient evalu logist regress outcom abdomin site infect outcom mortal signific correl apach II score residu effect treatment assign signific improv outcom imipenem/cilastatin-tr patient differ outcom failur rate patient gram-neg organ tobramycin/clindamycin-tr patient incid fasciiti reoper prosthet fascial replac maximum peak tobramycin level tobramycin/clindamycin patient gram-neg organ maximum peak micrograms/ml time peak day maximum peak micrograms/ml day studi inclus sever statist analys outcom result notion imipenem/cilastatin therapi intra-abdomin site infect amino-glycoside-bas regimen